Public policy symposium: the legal, ethical, and economic impact of patient material used for product development in the biomedical industry.
D037881:Aborted Fetus; D035843:Biomedical Research; D002102:Cadaver; D016265:Conflict of Interest; D004274:DNA, Recombinant; D004467:Economics; D004989:Ethics; D005249:Fees and Charges; D005333:Fetus; D018594:Human Body; D006805:Human Experimentation; D006801:Humans; D007221:Industry; D007258:Informed Consent; D007315:Insemination, Artificial; D007391:International Cooperation; D038622:Internationality; D007603:Jurisprudence; D010067:Ownership; D010330:Patents as Topic; D010344:Patient Advocacy; D028701:Patient Rights; D010817:Physician-Patient Relations; D011640:Public Policy; D012106:Research; D012108:Research Personnel; D035844:Researcher-Subject Relations; D013094:Spermatozoa; D020458:Third-Party Consent; D014019:Tissue Donors; D009927:Tissue and Organ Procurement; D014481:United States; D014495:Universities
Biomedical and Behavioral Research; Health Care and Public Health; Legal Approach; Professional Patient Relationship; University of California, San Diego